0001213900-19-025247.txt : 20191203 0001213900-19-025247.hdr.sgml : 20191203 20191203194106 ACCESSION NUMBER: 0001213900-19-025247 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191129 FILED AS OF DATE: 20191203 DATE AS OF CHANGE: 20191203 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ROCAMBOLI STEPHEN CENTRAL INDEX KEY: 0001221451 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39102 FILM NUMBER: 191267005 MAIL ADDRESS: STREET 1: C/OPARMOUNT CAPITAL STREET 2: 787 SEVENTH AVE 48TH FL CITY: NEW YORK STATE: NY ZIP: 10019 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TFF Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001733413 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 824344737 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2600 VIA FORTUNA, SUITE 360 CITY: AUSTIN STATE: TX ZIP: 78746 BUSINESS PHONE: 737-802-1973 MAIL ADDRESS: STREET 1: 2600 VIA FORTUNA, SUITE 360 CITY: AUSTIN STATE: TX ZIP: 78746 4 1 ownership.xml OWNERSHIP DOCUMENT X0306 4 2019-11-29 0 0001733413 TFF Pharmaceuticals, Inc. TFFP 0001221451 ROCAMBOLI STEPHEN 2600 VIA FORTUNA, SUITE 360 AUSTIN TX 78746 1 0 0 0 Stock Options (Right to Buy) 5.00 2019-11-29 4 A 0 3623 0.00 A 2029-10-29 Common Stock 3623 139429 D 25% of the options vest on the first anniversary of the grant and the remainder vest in equal quarterly installments over the next three years. /s/ Stephen C. Rocamboli, by Kirk Allen Coleman, as Attorney-in-Fact 2019-12-03